LUPRON DEPOT Drug Patent Profile
✉ Email this page to a colleague
When do Lupron Depot patents expire, and when can generic versions of Lupron Depot launch?
Lupron Depot is a drug marketed by Abbvie Endocrine Inc and is included in five NDAs. There are two patents protecting this drug.
This drug has thirty-five patent family members in twenty-eight countries.
The generic ingredient in LUPRON DEPOT is leuprolide acetate. There are twenty-two drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lupron Depot
A generic version of LUPRON DEPOT was approved as leuprolide acetate by SANDOZ on August 4th, 1998.
Summary for LUPRON DEPOT
International Patents: | 35 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Clinical Trials: | 132 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LUPRON DEPOT |
What excipients (inactive ingredients) are in LUPRON DEPOT? | LUPRON DEPOT excipients list |
DailyMed Link: | LUPRON DEPOT at DailyMed |
Recent Clinical Trials for LUPRON DEPOT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Emory University | Phase 4 |
National Cancer Institute (NCI) | Phase 4 |
Syneos Health | Phase 2 |
US Patents and Regulatory Information for LUPRON DEPOT
LUPRON DEPOT is protected by one US patents.
Patents protecting LUPRON DEPOT
Sustained-release composition and method for producing the same
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: PALLIATIVE TREATMENT OF PROSTATE CANCER
Expired US Patents for LUPRON DEPOT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020517-001 | Dec 22, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020011-001 | Oct 22, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020517-001 | Dec 22, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020011-001 | Oct 22, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 019732-001 | Jan 26, 1989 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020517-002 | May 30, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LUPRON DEPOT
See the table below for patents covering LUPRON DEPOT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hungary | T56268 | ⤷ Try a Trial | |
Japan | 4819173 | ⤷ Try a Trial | |
Japan | H0678425 | ⤷ Try a Trial | |
China | 1868458 | ⤷ Try a Trial | |
Malaysia | 148370 | SUSTAINED-RELEASE COMPOSITION AND METHOD FOR PRODUCING THE SAME | ⤷ Try a Trial |
Japan | 3277342 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |